The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
==================================================================================================================================

* Marisa O Peluso
* Ammar Adam
* Caroline M Armet
* Li Zhang
* Rachel W O’Connor
* Benjamin H Lee
* Andrew C Lake
* Emmanuel Normant
* Scott C Chappel
* Jonathan A Hill
* Vito J Palombella
* Pamela M Holland
* Alison M Paterson